Cargando…
Antidepressant-like properties of sarizotan in experimental Parkinsonism
RATIONALE: Depression and anxiety are common symptoms in Parkinson's disease for which there are no optimal treatments. Sarizotan, an agonist at serotonin receptors and partial agonist at dopamine D(2)-like receptors, has shown antidyskinetic effects in Parkinson's disease. Based on its ph...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer-Verlag
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3222806/ https://www.ncbi.nlm.nih.gov/pubmed/21647579 http://dx.doi.org/10.1007/s00213-011-2356-7 |